Budge James 4

4 · Hinge Health, Inc. · Filed Mar 24, 2026

AI-generated summary of this filing

Updated Mar 24, 2026

Hinge Health (HNGE) CFO Budge James Sells 11,006 Shares

What Happened

Hinge Health CFO Budge James sold a total of 11,006 shares in three open‑market transactions on March 23, 2026, for aggregate proceeds of roughly $465,138. The individual trades were: 1,988 shares at $41.29 ($82,076), 8,346 shares at $42.45 ($354,299), and 672 shares at $42.80 ($28,763). These were disposals (sales), not purchases.

Key Details

Transaction date: 2026-03-23; Form 4 filed 2026-03-24 (appears timely).
Individual trades and reported prices/values:
- 1,988 shares @ $41.29 = $82,076 (weighted avg range reported: $40.73–$41.69).
- 8,346 shares @ $42.45 = $354,299 (weighted avg range reported: $41.78–$42.77).
- 672 shares @ $42.80 = $28,763 (weighted avg range reported: $42.78–$42.87).
Total shares sold: 11,006; total proceeds: about $465,138.
Shares owned after transaction: not disclosed in the provided filing excerpt.
Footnotes: Sales were effected pursuant to a Rule 10b5‑1 trading plan adopted June 12, 2025 (pre‑planned sales). Footnotes also provide weighted‑average price ranges and offer to provide breakdowns by price upon request.

Context

These were planned sales under a Rule 10b5‑1 plan, which allows insiders to pre‑specify trades and is commonly used to avoid trading on nonpublic information. Such sales are often routine and do not, by themselves, indicate the insider’s current view of company prospects.

Form 4

Period: 2026-03-23

Chief Financial Officer

Transactions

Sale
Class A Common Stock
[F1][F2]
2026-03-23$41.29/sh−1,988$82,076→ 410,445 total
Sale
Class A Common Stock
[F1][F3]
2026-03-23$42.45/sh−8,346$354,299→ 402,099 total
Sale
Class A Common Stock
[F1][F4]
2026-03-23$42.80/sh−672$28,763→ 401,427 total

Footnotes (4)

[F1]The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.
[F2]Represents the weighted average sale price. The lowest price at which shares were sold was $40.73 and the highest price at which shares were sold was $41.69. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
[F3]Represents the weighted average sale price. The lowest price at which shares were sold was $41.78 and the highest price at which shares were sold was $42.77. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
[F4]Represents the weighted average sale price. The lowest price at which shares were sold was $42.78 and the highest price at which shares were sold was $42.87. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

Signature

/s/ James Budge|2026-03-24

1 file